Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 554 of 5804
-
New scans and blood tests aim to catch pancreatic cancer early without surgery
Diagnosis Recruiting nowThe purpose of this study is for researchers to find ways of detecting pancreatic ductal adenocarcinoma/PDAC early to avoid the invasive procedure of surgery. The study researchers think a combination of imaging and a series of blood tests may be an effective way to detect PDAC e…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
New heart pump takes on ECMO in High-Stakes stenting trial
Disease control OngoingIn patients with complex coronary artery disease (CAD), determining the optimal revascularization strategy (percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) remains a challenge. These high-risk patients pose an extreme surgical risk. However, wit…
Phase: NA • Sponsor: Shenzhen Core Medical Technology CO.,LTD. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug could free diabetics from insulin after cell transplant
Disease control Recruiting nowTegoprubart (AT-1501) is a monoclonal antibody. Antibodies are Y-shaped proteins that are produced naturally by the subject's immune system to attack and fight foreign substances that cause illness. Monoclonal antibodies are man-made proteins manufactured to serve as substitute a…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New cell therapy aims to tame deadly transplant complication
Disease control OngoingThis study is a prospective randomized placebo-controlled phase 2 study to compare CYP-001 plus corticosteroids (CS) to placebo plus CS in allogeneic hematologic stem cell transplant recipients with HR-aGvHD. Severity of GvHD will be assessed at screening and throughout the study…
Phase: PHASE2 • Sponsor: Cynata Therapeutics Limited • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Engineered immune cells take on hard-to-treat prostate cancer
Disease control OngoingThis is one center, single-arm, open-label investigator initiated trial to assess the safety and efficacy of enhanced autologous PSMA chimeric antigen receptor T cells in the treatment for patients with refractory castration resistant prostate cancer, and the sample size is set t…
Phase: EARLY_PHASE1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug combo shows promise against tough esophageal cancer
Disease control OngoingDefinitive chemoradiotherapy (CRT) is the standard treatment option for unresectable locally advanced esophageal cancer. However, as high as more than 40% of patients with esophageal cancer experienced locoregional recurrence after definitive CRT. Immune checkpoint inhibitors tar…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Sound waves zapping kidney fat could lower blood pressure
Disease control Recruiting nowThis seamless two-stage phase II/III clinical trial aims to evaluate the efficacy and safety of a novel focused power ultrasound mediated inferior perirenal adipose tissue modification therapy for essential hypertension. Stage 1 is a phase II, multicenter, open-label, randomized …
Phase: NA • Sponsor: Suzhou Municipal Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could a chemo drug shrink prostate tumors in men with BRCA mutations?
Disease control Recruiting nowThis phase II trial tests how well carboplatin before surgery works in treating patients with high-risk prostate cancer and an inherited BRCA1 or BRCA2 gene mutation. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the…
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New hope for tough pancreatic cancer: combo therapy with or without radiation
Disease control Recruiting nowThis study is a single-arm, multi-center, multi-cohort, prospective clinical study initiated by the investigator. The indication of this study is: patients with advanced metastatic pancreatic cancer who have progressed after first-line chemotherapy. Eligible patients will be ass…
Phase: PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Veterans with lung cancer may benefit from triple therapy approach
Disease control Recruiting nowThis study is a multicenter Phase II single arm trial to assess the safety and efficacy of chemotherapy and immunotherapy followed by radiotherapy in patients with unresectable Stage III NSCLC.
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New pill may stop COVID-19 after exposure – trial underway
Prevention Recruiting nowAdults who do not have major health, kidney, gastrointestinal disease will be randomized to receive oral mitoquinone/mitoquinol mesylate (Mito-MES) versus placebo to prevent the development and progression of COVID-19 after high-risk exposure to a person with confirmed SARS-CoV-2…
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC
-
Which surgery is better for advanced stomach cancer after Chemo-Immunotherapy?
Disease control Recruiting nowWe plan to evaluate the efficacy and safety of proximal gastric vs. total gastric radical resection after SOX combined with anti-PD-1 neoadjuvant therapy in locally advanced upper gastric cancer
Phase: NA • Sponsor: Guihua Wang • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New MRI technique could end guesswork in brain tumor Follow-Up
Diagnosis OngoingBackground: Differentiating true progression (TP) from pseudoprogression (PsP) after glioma surgery remains a major clinical challenge because conventional magnetic resonance imaging (MRI) often cannot reliably distinguish these conditions. Objective: This prospective observatio…
Sponsor: Lanzhou University Second Hospital • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
New drug aimed at stubborn high blood pressure passes final trial phase
Disease control CompletedThis is a Phase III, multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the safety, tolerability and the effect of 2 mg Baxdrostat vs. placebo, administered QD orally, on the reduction of SBP, measured by average 24-hour ABPM in 212 partic…
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Targeted physiotherapy may speed pelvic recovery after delivery
Symptom relief CompletedThis study evaluated whether a 12-week exercise-based sensorimotor physiotherapy program could improve pelvic health and functional recovery in postpartum women. Participants were women aged 18-40 years who were between 6 weeks and 6 months after a singleton delivery. They were r…
Phase: NA • Sponsor: Özge BAYKAN ÇOPUROĞLU • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
New daily pill aims to crush stubborn cholesterol in High-Risk patients
Disease control CompletedThe study is a placebo-controlled, double-blind, randomized, phase 3 study in participants with heterozygous familial hypercholesterolemia (HeFH) and/or atherosclerotic cardiovascular disease (ASCVD) or multiple ASCVD risk factors to evaluate the efficacy, safety and tolerability…
Phase: PHASE3 • Sponsor: NewAmsterdam Pharma • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New MRI-guided radiation aims to spare brain tissue in lung cancer patients
Disease control Recruiting nowThis study aims to explore the safety and efficacy of eliminating the planning target volume (PTV) margins based on MRI-guided adaptive stereotactic radiotherapy for non-small cell lung cancer (NSCLC) patients with brain metastasis.
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New dissolving heart implant could ease migraines without metal side effects
Symptom relief Recruiting nowMigraine is one of the most common chronic neurological disorders, posing a significant global public health concern. Patent Foramen Ovale (PFO) is the most common congenital heart anomaly in adults. Mechanisms linking PFO to migraine include cortical spreading depression, vascul…
Phase: NA • Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Radiation boosts immunotherapy in lung cancer trial
Disease control Recruiting nowThis is a randomized, controlled, open-label, multicenter phase II clinical trial comparing the efficacy and safety of low-dose radiation therapy and stereotactic body radiation therapy combined with PD-1 inhibitor (sintilimab) and standard platinum-based doublet chemotherapy ver…
Phase: PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could your own bone marrow ease incurable chest pain?
Symptom relief Recruiting nowREGENERATE-COBRA will examine whether autologous stem cell treatment can improve angina symptoms and quality of life for patients with refractory angina. Patients will be randomised (randomly allocated with a 50:50 chance) to either the 'treatment' or the 'sham' group - they will…
Phase: PHASE2 • Sponsor: Barts & The London NHS Trust • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC